Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

Recruiting

Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.

Trial locations(1 site)

China

Huashan Hospital Affiliated to Fudan University, Shanghai, Shanghai Municipality